Post-marketing safety of finerenone: a disproportionality analysis of the FDA adverse event reporting system
Year: 2024
Type: article
Source: Expert Opinion on Drug Safety
Institution: Ningbo University
Language: English
Subfield: Toxicology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4401722839
